Author:
Scherf-Clavel Oliver,Kinzig Martina,Besa Axel,Schreiber André,Bidmon Clemens,Abdel-Tawab Mona,Wohlfart Jonas,Sörgel Fritz,Holzgrabe Ulrike
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference20 articles.
1. Valsartan: Charchenbezogener Rückruf valsartanhaltiger Arzneimittel, deren Wirkstoff von dem chinesischen Hersteller Zhejiang Huahai Pharmaceutical produziert wurde. Bundesinstitut für Arzneimittel und Medizinprodukte,2019
2. Noch mehr nitrosamine;Buschmann;DAZ,2019
3. Dimethylamine as the key intermediate generated in situ from dimethylformamide (DMF) for the synthesis of thioamides;Liu;Beilstein J. Org. Chem.,2015
4. On-line HPLC-tandem mass spectrometry analysis of contaminants of L-tryptophan associated with the onset of the eosinophilia-myalgia syndrome;Williamson;Toxicol. Lett.,1997
5. An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use;Belongia;N. Engl. J. Med.,1990
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献